FDA Lets NeuroRx, Relief Therapeutics Test RLF-100 in COVID-19 Patients – The New York Times

ZURICH The U.S. Food and Drug Administration has granted NeuroRx Inc Investigational New Drug (IND) permission to test RLF-100 (aviptadil) for inhaled use in patients with moderate and severe COVID-1…
Read More